IL133004A - Pharmaceutical preparations consisting of a fermenting agent, Aldous and an ACE inhibitor - Google Patents

Pharmaceutical preparations consisting of a fermenting agent, Aldous and an ACE inhibitor

Info

Publication number
IL133004A
IL133004A IL13300498A IL13300498A IL133004A IL 133004 A IL133004 A IL 133004A IL 13300498 A IL13300498 A IL 13300498A IL 13300498 A IL13300498 A IL 13300498A IL 133004 A IL133004 A IL 133004A
Authority
IL
Israel
Prior art keywords
inhibitor
pharmaceutical composition
aldose reductase
pharmaceutically acceptable
reductase inhibitor
Prior art date
Application number
IL13300498A
Other languages
English (en)
Hebrew (he)
Other versions
IL133004A0 (en
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL133004A0 publication Critical patent/IL133004A0/xx
Publication of IL133004A publication Critical patent/IL133004A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13300498A 1997-07-08 1998-07-02 Pharmaceutical preparations consisting of a fermenting agent, Aldous and an ACE inhibitor IL133004A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714274.9A GB9714274D0 (en) 1997-07-08 1997-07-08 Pharmaceutical composition
PCT/GB1998/001959 WO1999002189A1 (en) 1997-07-08 1998-07-02 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor

Publications (2)

Publication Number Publication Date
IL133004A0 IL133004A0 (en) 2001-03-19
IL133004A true IL133004A (en) 2004-12-15

Family

ID=10815469

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13300498A IL133004A (en) 1997-07-08 1998-07-02 Pharmaceutical preparations consisting of a fermenting agent, Aldous and an ACE inhibitor

Country Status (28)

Country Link
US (1) US6337327B1 (cs)
EP (1) EP0991424B1 (cs)
JP (1) JP2002509540A (cs)
KR (1) KR20010015551A (cs)
CN (1) CN1186097C (cs)
AT (1) ATE205402T1 (cs)
AU (1) AU746211B2 (cs)
BR (1) BR9810570A (cs)
CA (1) CA2292451A1 (cs)
CZ (1) CZ290276B6 (cs)
DE (1) DE69801661T2 (cs)
DK (1) DK0991424T3 (cs)
ES (1) ES2163283T3 (cs)
GB (1) GB9714274D0 (cs)
HK (1) HK1028876A1 (cs)
HU (1) HU224009B1 (cs)
ID (1) ID24597A (cs)
IL (1) IL133004A (cs)
NO (1) NO20000045L (cs)
NZ (1) NZ501165A (cs)
PL (1) PL337925A1 (cs)
PT (1) PT991424E (cs)
RU (1) RU2216354C2 (cs)
SK (1) SK122000A3 (cs)
TR (1) TR199903026T2 (cs)
UA (1) UA64761C2 (cs)
WO (1) WO1999002189A1 (cs)
ZA (1) ZA985993B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) * 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
WO2001064205A2 (en) * 2000-03-02 2001-09-07 The Institutes For Pharmaceutical Discovery, Llc Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
AU2002355419A1 (en) * 2001-08-06 2003-02-24 Genomed, Llc Methods and compositions for treating diseases associated with excesses in ace
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
WO2003046165A1 (en) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
EA201891154A1 (ru) 2011-10-28 2019-02-28 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
WO2014022291A1 (en) * 2012-07-28 2014-02-06 The Regents Of The University Of Colorado, A Body Corporate Compounds reducing the production of sorbitol in the eye and methods of using the same
CN103063794B (zh) * 2012-12-24 2014-08-06 扬子江药业集团南京海陵药业有限公司 一种依帕司他片的含量检测控制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications

Also Published As

Publication number Publication date
NO20000045D0 (no) 2000-01-06
WO1999002189A1 (en) 1999-01-21
CZ290276B6 (cs) 2002-06-12
CA2292451A1 (en) 1999-01-21
CN1186097C (zh) 2005-01-26
GB9714274D0 (en) 1997-09-10
UA64761C2 (uk) 2004-03-15
DE69801661D1 (de) 2001-10-18
HK1028876A1 (en) 2001-03-09
KR20010015551A (ko) 2001-02-26
RU2216354C2 (ru) 2003-11-20
ES2163283T3 (es) 2002-01-16
EP0991424B1 (en) 2001-09-12
EP0991424A1 (en) 2000-04-12
IL133004A0 (en) 2001-03-19
ID24597A (id) 2000-07-27
HUP0002644A2 (hu) 2000-12-28
CN1261804A (zh) 2000-08-02
NZ501165A (en) 2001-06-29
CZ200017A3 (cs) 2000-05-17
TR199903026T2 (xx) 2000-04-21
HU224009B1 (hu) 2005-04-28
ZA985993B (en) 1999-01-18
JP2002509540A (ja) 2002-03-26
DK0991424T3 (da) 2001-12-03
AU8229698A (en) 1999-02-08
US6337327B1 (en) 2002-01-08
PL337925A1 (en) 2000-09-11
ATE205402T1 (de) 2001-09-15
NO20000045L (no) 2000-01-06
SK122000A3 (en) 2000-06-12
DE69801661T2 (de) 2002-07-04
AU746211B2 (en) 2002-04-18
PT991424E (pt) 2002-02-28
BR9810570A (pt) 2000-09-19

Similar Documents

Publication Publication Date Title
EP1897546B1 (en) Combined compositions comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid
US8067444B2 (en) Pyridoxamine for the treatment of diabetic intermediaries and post-amadori inhibition
EP0991424B1 (en) Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
US20160045481A1 (en) Pyridoxamine for the Treatment of Diabetic Kidney Disease
MXPA00000103A (en) Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
AU2003255176B2 (en) Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
AU2007200367B2 (en) Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees